kongre.net
Welcome to kongre.net

Speaker

Nathalie Belmonte

Chief Science & Technical Officer, Quell Therapeutics

Nathalie Belmonte, Chief Science & Technical Officer at Quell Therapeutics, is speaking at 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026) in the session “Exploring Preclinical & Translational Strategies to Advance Autoimmune Cell Therapy Toward Clinical Readiness”.

Conferences
1
Keynotes
0
Upcoming
1

Upcoming appearances

More speakers at 4th Cell Therapy for Autoimmune Disease Summit 2026

  • Fred Aslan

    President & Chief Executive Officer, Artiva Biotherapeutics, Inc

  • Rena Baek

    Executive Director, Preclinical Development, Moderna

  • Michael Mingueneau

    Vice President, Immunology, Sail Biomedicines

  • Daniel Shelly

    Chief Business Development Officer, PolTREG

  • Edward Zhang

    Co-Founder & Chief Executive Officer, Overland Therapeutics

  • Mark Bach

    Chief Medical Officer, GentiBio

See all 22 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Nathalie Belmonte, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].